This study demonstrated that an LL-37/Renalexin hybrid peptide exhibits antimicrobial activity at lower concentrations than either peptide alone. The hybrid approach against multidrug-resistant ESKAPE pathogens shows promise for overcoming antibiotic resistance.
Narh, Julius Kwesi; Casillas-Vega, Nestor G; Zarate, Xristo